Stock Exchange and the Stakeholders are requested to take on record unaudited financial results for the quarter ended 31st December, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shentracon Chemicals has reported zero revenue from operations for the third quarter and the nine months ended December 2025, indicating no active business activity. Other income also dropped to nil in Q3 from ₹9.72 lakh a year ago. The company posted a net loss of ₹0.82 lakh in Q3 FY26 versus a profit of ₹4.43 lakh in Q3 FY25, while the nine-month loss widened sharply to ₹42.08 lakh, impacted by an exceptional item of ₹47.20 lakh booked in Q2 FY26. Total expenses were minimal at ₹0.82 lakh for the quarter, mostly employee costs. The statutory auditor MARK & Co. issued an unmodified limited review report with no qualifications.
For shareholders, this is a deeply worrying picture — no operating revenue, recurring losses, and a large exceptional charge have eroded equity (other equity at zero). The stock is likely to remain under pressure until the company demonstrates a revival in business operations or a credible revenue-generating plan.